Casdin Capital as of March 31, 2019
Portfolio Holdings for Casdin Capital
Casdin Capital holds 29 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spark Therapeutics | 11.8 | $107M | 940k | 113.88 | |
| Blueprint Medicines (BPMC) | 7.5 | $68M | 849k | 80.05 | |
| Myokardia | 7.3 | $67M | 1.3M | 51.99 | |
| Sage Therapeutics (SAGE) | 7.0 | $64M | 400k | 159.05 | |
| Bluebird Bio (BLUE) | 6.2 | $56M | 358k | 157.33 | |
| Invitae (NVTAQ) | 5.7 | $52M | 2.2M | 23.42 | |
| Fate Therapeutics (FATE) | 4.9 | $45M | 2.6M | 17.57 | |
| Magenta Therapeutics | 4.8 | $44M | 2.6M | 16.47 | |
| Biolife Solutions (BLFS) | 4.8 | $43M | 2.4M | 17.89 | |
| Alnylam Pharmaceuticals (ALNY) | 4.6 | $42M | 445k | 93.45 | |
| Codexis (CDXS) | 4.6 | $42M | 2.0M | 20.53 | |
| Audentes Therapeutics | 4.3 | $39M | 1.0M | 39.02 | |
| Sarepta Therapeutics (SRPT) | 4.0 | $36M | 305k | 119.19 | |
| GenMark Diagnostics | 2.6 | $24M | 3.4M | 7.09 | |
| Agios Pharmaceuticals (AGIO) | 2.5 | $23M | 335k | 67.44 | |
| Voyager Therapeutics (VYGR) | 2.4 | $22M | 1.1M | 19.14 | |
| Constellation Pharmceticls I | 2.3 | $21M | 1.6M | 13.55 | |
| Illumina (ILMN) | 2.0 | $19M | 60k | 310.68 | |
| Global Blood Therapeutics In | 1.7 | $16M | 300k | 52.93 | |
| Gritstone Oncology Ord (GRTSQ) | 1.6 | $15M | 1.1M | 13.30 | |
| Editas Medicine (EDIT) | 1.3 | $12M | 480k | 24.45 | |
| Sangamo Biosciences (SGMO) | 1.1 | $10M | 1.1M | 9.54 | |
| Homology Medicines | 1.1 | $9.7M | 350k | 27.73 | |
| Beigene | 1.0 | $9.2M | 70k | 132.00 | |
| Evolent Health (EVH) | 0.8 | $6.9M | 550k | 12.58 | |
| Caredx (CDNA) | 0.7 | $6.3M | 200k | 31.52 | |
| Alector (ALEC) | 0.7 | $6.2M | 331k | 18.72 | |
| Gilead Sciences (GILD) | 0.6 | $5.2M | 80k | 65.01 | |
| Denali Therapeutics (DNLI) | 0.3 | $2.3M | 100k | 23.22 |
